Synthesis, in vitro and in vivo pharmacology of a C-11 labeled analog of CP-101,606, (±)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4- (p-[11C]methoxyphenyl)piperidino]-1-propanol, as a PET tracer for NR2B subunit-containing NMDA receptors

Terushi Haradahira, Jun Maeda, Takashi Okauchi, Ming Rong Zhang, Junko Hojo, Takayo Kida, Takuya Arai, Fumihiko Yamamoto, Shigeki Sasaki, Minoru Maeda, Kazutoshi Suzuki, Tetsuya Suhara

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

A carbon-11 labeled methoxyl analog of CP-101,606, (±)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4-(p-[11C] methoxyphenyl)piperidino]-1-propanol [(±)[11C]1], was synthesized as a new subtype-selective PET radioligand for NMDA receptors. The in vitro binding studies using rat brain slices demonstrated that (±)[11C]1 shows an extremely high-specific binding to the NR2B subunit of NMDA receptors. In contrast to the in vitro binding, the in vivo binding to mouse and monkey brains showed no apparent specific localization of the radioactivity in any of the brain regions. Metabolism and physicochemical properties such as the lipophilicity of (±)[11C]1 seemed unlikely to affect the in vivo (±)[11C]1 binding. Among the various endogenous ligands acting at the NMDA receptors, polyamines (spermine and spermidine) and divalent cations (Mg2+, Zn2+, and Ca2+) strongly inhibited the in vitro (±)[11C]1 binding. Thus, the present studies point to the possibility that the polyamines and cations behave as endogenous inhibitors for (±)[11C]1 binding, leading to the loss of the specific binding in vivo.

Original languageEnglish
Pages (from-to)517-525
Number of pages9
JournalNuclear Medicine and Biology
Volume29
Issue number5
DOIs
Publication statusPublished - Jul 2 2002

Fingerprint

1-Propanol
N-Methyl-D-Aspartate Receptors
Polyamines
Pharmacology
Brain
Spermidine
Spermine
Divalent Cations
Radioactivity
Haplorhini
Cations
Carbon
Ligands
traxoprodil mesylate
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Synthesis, in vitro and in vivo pharmacology of a C-11 labeled analog of CP-101,606, (±)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4- (p-[11C]methoxyphenyl)piperidino]-1-propanol, as a PET tracer for NR2B subunit-containing NMDA receptors. / Haradahira, Terushi; Maeda, Jun; Okauchi, Takashi; Zhang, Ming Rong; Hojo, Junko; Kida, Takayo; Arai, Takuya; Yamamoto, Fumihiko; Sasaki, Shigeki; Maeda, Minoru; Suzuki, Kazutoshi; Suhara, Tetsuya.

In: Nuclear Medicine and Biology, Vol. 29, No. 5, 02.07.2002, p. 517-525.

Research output: Contribution to journalArticle

Haradahira, Terushi ; Maeda, Jun ; Okauchi, Takashi ; Zhang, Ming Rong ; Hojo, Junko ; Kida, Takayo ; Arai, Takuya ; Yamamoto, Fumihiko ; Sasaki, Shigeki ; Maeda, Minoru ; Suzuki, Kazutoshi ; Suhara, Tetsuya. / Synthesis, in vitro and in vivo pharmacology of a C-11 labeled analog of CP-101,606, (±)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4- (p-[11C]methoxyphenyl)piperidino]-1-propanol, as a PET tracer for NR2B subunit-containing NMDA receptors. In: Nuclear Medicine and Biology. 2002 ; Vol. 29, No. 5. pp. 517-525.
@article{6471fc466fc847a2aa2abfc566dac76b,
title = "Synthesis, in vitro and in vivo pharmacology of a C-11 labeled analog of CP-101,606, (±)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4- (p-[11C]methoxyphenyl)piperidino]-1-propanol, as a PET tracer for NR2B subunit-containing NMDA receptors",
abstract = "A carbon-11 labeled methoxyl analog of CP-101,606, (±)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4-(p-[11C] methoxyphenyl)piperidino]-1-propanol [(±)[11C]1], was synthesized as a new subtype-selective PET radioligand for NMDA receptors. The in vitro binding studies using rat brain slices demonstrated that (±)[11C]1 shows an extremely high-specific binding to the NR2B subunit of NMDA receptors. In contrast to the in vitro binding, the in vivo binding to mouse and monkey brains showed no apparent specific localization of the radioactivity in any of the brain regions. Metabolism and physicochemical properties such as the lipophilicity of (±)[11C]1 seemed unlikely to affect the in vivo (±)[11C]1 binding. Among the various endogenous ligands acting at the NMDA receptors, polyamines (spermine and spermidine) and divalent cations (Mg2+, Zn2+, and Ca2+) strongly inhibited the in vitro (±)[11C]1 binding. Thus, the present studies point to the possibility that the polyamines and cations behave as endogenous inhibitors for (±)[11C]1 binding, leading to the loss of the specific binding in vivo.",
author = "Terushi Haradahira and Jun Maeda and Takashi Okauchi and Zhang, {Ming Rong} and Junko Hojo and Takayo Kida and Takuya Arai and Fumihiko Yamamoto and Shigeki Sasaki and Minoru Maeda and Kazutoshi Suzuki and Tetsuya Suhara",
year = "2002",
month = "7",
day = "2",
doi = "10.1016/S0969-8051(02)00301-3",
language = "English",
volume = "29",
pages = "517--525",
journal = "Nuclear Medicine and Biology",
issn = "0969-8051",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Synthesis, in vitro and in vivo pharmacology of a C-11 labeled analog of CP-101,606, (±)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4- (p-[11C]methoxyphenyl)piperidino]-1-propanol, as a PET tracer for NR2B subunit-containing NMDA receptors

AU - Haradahira, Terushi

AU - Maeda, Jun

AU - Okauchi, Takashi

AU - Zhang, Ming Rong

AU - Hojo, Junko

AU - Kida, Takayo

AU - Arai, Takuya

AU - Yamamoto, Fumihiko

AU - Sasaki, Shigeki

AU - Maeda, Minoru

AU - Suzuki, Kazutoshi

AU - Suhara, Tetsuya

PY - 2002/7/2

Y1 - 2002/7/2

N2 - A carbon-11 labeled methoxyl analog of CP-101,606, (±)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4-(p-[11C] methoxyphenyl)piperidino]-1-propanol [(±)[11C]1], was synthesized as a new subtype-selective PET radioligand for NMDA receptors. The in vitro binding studies using rat brain slices demonstrated that (±)[11C]1 shows an extremely high-specific binding to the NR2B subunit of NMDA receptors. In contrast to the in vitro binding, the in vivo binding to mouse and monkey brains showed no apparent specific localization of the radioactivity in any of the brain regions. Metabolism and physicochemical properties such as the lipophilicity of (±)[11C]1 seemed unlikely to affect the in vivo (±)[11C]1 binding. Among the various endogenous ligands acting at the NMDA receptors, polyamines (spermine and spermidine) and divalent cations (Mg2+, Zn2+, and Ca2+) strongly inhibited the in vitro (±)[11C]1 binding. Thus, the present studies point to the possibility that the polyamines and cations behave as endogenous inhibitors for (±)[11C]1 binding, leading to the loss of the specific binding in vivo.

AB - A carbon-11 labeled methoxyl analog of CP-101,606, (±)threo-1-(4-hydroxyphenyl)-2-[4-hydroxy-4-(p-[11C] methoxyphenyl)piperidino]-1-propanol [(±)[11C]1], was synthesized as a new subtype-selective PET radioligand for NMDA receptors. The in vitro binding studies using rat brain slices demonstrated that (±)[11C]1 shows an extremely high-specific binding to the NR2B subunit of NMDA receptors. In contrast to the in vitro binding, the in vivo binding to mouse and monkey brains showed no apparent specific localization of the radioactivity in any of the brain regions. Metabolism and physicochemical properties such as the lipophilicity of (±)[11C]1 seemed unlikely to affect the in vivo (±)[11C]1 binding. Among the various endogenous ligands acting at the NMDA receptors, polyamines (spermine and spermidine) and divalent cations (Mg2+, Zn2+, and Ca2+) strongly inhibited the in vitro (±)[11C]1 binding. Thus, the present studies point to the possibility that the polyamines and cations behave as endogenous inhibitors for (±)[11C]1 binding, leading to the loss of the specific binding in vivo.

UR - http://www.scopus.com/inward/record.url?scp=0035999183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035999183&partnerID=8YFLogxK

U2 - 10.1016/S0969-8051(02)00301-3

DO - 10.1016/S0969-8051(02)00301-3

M3 - Article

VL - 29

SP - 517

EP - 525

JO - Nuclear Medicine and Biology

JF - Nuclear Medicine and Biology

SN - 0969-8051

IS - 5

ER -